TrueBlue, Inc. (TBI) Stock Overview
Explore TrueBlue, Inc.’s financial performance, market position, analyst ratings, and future outlook.
TrueBlue, Inc. (TBI)
Key Financials
Key Financials
Market Cap
310.7M
P/E Ratio
-5.46
EPS (TTM)
$-0.57
ROE
-0.21%
TBI Stock Analysis & Investment Overview (NYSE)
Our AI-powered analysis of TrueBlue, Inc. (NYSE: TBI) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, TrueBlue, Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of TBI on the NYSE shows an RSI of 67.69, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $5.97 for the NYSE listing.
Key metrics behind TrueBlue, Inc.'s NYSE-traded stock include a P/E ratio of -5.46 and a market capitalization of 310.7M. Combined with our AI analysis, these give both institutional and retail investors a clear view of TBI on the NYSE.